PubMed_ Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients https://t.co/E52oGDFtfd
166 followers
17 followers
We are excited to announce the publication of our @CloneSight MRD test results in CART cells treated patients. Based on these results, we will launch a new product to quantify CAR-T cells and tumor cells (MRD) in the same assay. https://t.co/ftAKvpEhqZ h
76 followers
RT @FrontImmunol: New Research: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chi…
190 followers
RT @FrontImmunol: New Research: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chi…